Publications

  • OPA Bulletin - April 30, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Your questions answered on recent proposed pharmacy regulations from Ontario government
    • Canadian Foundation for Pharmacy happenings
    • Pharmacies surpass doctors’ offices as primary venue for influenza vaccination
    • OPA represents at Momentum Loblaw/SDM trade show

    • An Update on Direct Oral Anticoagulation
    • Essential Cannabis Knowledge for Pharmacists - Certificate Program
    • Patient Assessment and Triage

    • First 100 will save $100 on conference registration
    • Ask the Practice Support Network
    • Spring time discounts with Royal Ontario Museum
    • Reminder to members in voting districts

    • Life Insurance v.s. Mortgage Insurance

    • DDD Notice No. 19066 posted April 25, 2019 Notice: Proposals to Establish More Efficient Pharmacy Reimbursement Policies
    • DDD Notice No. 19067 posted April 26, 2019 Notice from the Executive Officer
    • DDD Notice No. 19068 posted April 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19069 posted April 30, 2019 Prescription Forgery Alert

    • Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
    • Health Product InfoWatch
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion

  • eDIRC: Prevention of Migraines in Adults

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    April 25, 2019 volume 17 no 9

  • OPA Bulletin - April 23, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Announcement to expand scope of practice for pharmacists generates public discussion
    • Apply to the Allied Health Professional Development Fund for Compensation of Conference Fees
    • OPA Celebrates National Immunization Awareness Week with Record Breaking Year for Flu Shots
    • Attention Pharmacies in Timmins, Cornwall, Kapuskasing and Thunder Bay - Potential Increase in NIHB Claims

    • An Update On Oral Anticoagulation
    • Managing Your Pharmacy: The Business Essentials
    • Assessing and Prescribing for Minor Ailments - Full Program

    • Meet the Future Leaders in Research at PxP2019
    • Ask the Customer Experience and Administration Team

    • Ask Us Your Questions on Critical Illness

    • ODB Formulary – Edition No. 43, Summary of Changes – April 2019 Summary of Product Changes

    • Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tablets because of nitrosamine impurity
    • Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation

  • OPA Bulletin - April 16, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Provincial Budget Announces Expansion of Scope of Practice for Pharmacists
    • Conference Early Bird Deadline is Thursday
    • Express Scripts Canada - Pharmacy Provider Manual

    • Take-home Naloxone in Community Pharmacies
    • Methadone and Buprenorphine/ Naloxone Toolkit
    • Opioid Addictions and Substitution Therapy Online Modules

    • PxP2019 Conference Social Events
    • Ask the Practice Support Network

    • Are You Prepared for a Critical Illness?

    • DDD Notice No. 19062 posted April 12, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Zinecard (Dexrazoxane)
    • Health Canada approves updates to Mifegymiso prescribing information

  • eDIRC: OCP-Recognized Cannabis Education Program Available Now!

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    April 11, 2019 volume 17 no 8

  • OPA Bulletin - April 09, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OHIP+ Update
    • Conference Early Bird Deadline is April 18
    • Patient Tip Sheet - Managing a Diet While Taking Warfarin
    • April is IBS Awareness Month - Read our Blog Post for Pharmacists
    • Ontario College of Pharmacists Annual Report

    • NEW! Medical Devices Training for Pharmacy Technicians
    • Collaboration with Family Physicians: the Rx for Success
    • FAQs and a New Drug Update on Contraception and Abortion Care
    • Potential Funding Available for OPA Professional Development

    • Time-Limited WebCrasher Savings with OPA Partner, Dell
    • PxP2019 Speaker Spotlight: Women's Health, Polypharmacy and T2D
    • OPA Supports Partner in Naloxone Awareness Day at Queen's Park
    • Ask the Customer Experience and Administration Team

    • OPA Advantage Plus
    • Last Chance for Movie Tickets from COSECO

    • Drug Shortage / Supply Health System Alert: Dexrazoxane, Erwinia Asparaginase and Etoposide

    • Biocell breast implants - Information Update
    • BENLYSTA (belimumab) - Safety Alert

  • OPA Bulletin - April 02, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Launches CCCEP-accredited and OCP-approved Cannabis Program for Pharmacists
    • Additonal OHIP+ Resources
    • CPhA survey on ARB recalls and drug shortages
    • Canadian Foundation for Pharmacy's Innovation Showcase is April 23
    • Women in Pharmacy Leadership Summit: What's on your mind?
    • And the winner of the OPA Cup is ...

    • NEW for Pharmacy Technicians! Identifying Drug Interactions
    • NEW for Pharmacists! Paid Consultations - Opportunities and Timesavers
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists

    • Thank You to Those Who Submitted an OPA Award Nomination
    • PxP2019 Announces Keynote Speakers
    • Ask the Practice Support Network

    • Stay Insured When Leaving the Country with OPA's Emergency Travel Insurance
    • It's Movie Ticket Time with COSECO!

    • March Issue of Health Product InfoWatch Now Available

  • eDIRC: OHIP+: OPA Process Map and Pharmacy Tool

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    March 28, 2019 volume 17 no 7

  • OPA Bulletin - March 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Process Map and Pharmacy Tool for OHIP+
    • ICYMI: Empowering Canadian Pharmacy Practice
    • Pharmacy Experience Pharmacie 2019 is open for registration!
    • Research Study: The Ontario Digital Service and Ministry of Health and Long-Term Care
    • Canadian Federation of Pharmacy Campaign Drive 1 Million for 25
    • OPA Supports Broader Discussion on Impact of Removal of Private Label Ban

    • Implementing Smoking Cessation Services in the Pharmacy
    • Asthma Management: The Essentials
    • MedsCheck Refresh: Implementing the Revitalized Program

    • Last Call for OPA Awards
    • Ask the Customer Experience and Administration Team

    • OPA Secure Health Plan Q&A
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19057 posted March 20, 2019 Prescription Forgery Alert
    • DDD Notice No. 19058 posted March 21, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – March 2019
    • DDD Notice No. 19059 posted March 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms

    • Extraneal peritoneal dialysis solution - Advisory
    • Important Safety Information on DARZALEX (daratumumab) and Hepatitis B Virus Reactivation - Janssen Inc.

  • OPA Bulletin - March 19, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Preparing for OHIP+ Amendments
    • Federal Budget Promises Funding for Key Healthcare Areas
    • Assessing Barriers to High Quality Care for Diabetes Patients Across Ontario
    • ICYMI: OPA Answers Your Questions on Pharmacy in 2019 and Beyond

    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults
    • How To: Ontario's Pharmaceutical Opinion Program
    • The MASTER Plan for Diabetes Continuing Education Program

    • ICYMI: OPA Board Members Speak Out on Membership with OPA
    • Ask the Practice Support Network

    • Are You Insured Through Your Employer's Group Plan for Long-Term Disability (LTD)?
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19047 posted March 13, 2019 Prescription Forgery Alert
    • DDD Notice No. 19048 posted March 13, 2019 Notice from the Executive Officer: Buprenorphine/ Naloxone (Suboxone® and generics) Reimbursement Reminder under the Ontario Drug Benefit Program
    • DDD Notice No. 19049 posted March 13, 2019 OHIP+ FAQs for Patients and Pharmacists
    • DDD Notice No. 19053 posted March 15, 2019 CPSO Notices, February 2019
    • DDD Notice No. 19055 posted March 18, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGES NOTIFICATION TO ODP AGENCIES
    • DDD Notice No. 19056 posted March 19, 2019 Prescription Forgery Alert
    • Delay in NIHB Provider Payments

    • Xeljanz and Xeljanz XR (tofacitinib) - Information Update
    • Irbesartan - Information Update
    • TECENTRIQ (atezolizumab) - Important Safety Information

Back to top